The correlation between CCL17+CCL22 and FOXP3 expression within NPC and EBV+ GC tumors (Pearson’s r = 0.59 and 0.55, respectively) was similar to the correlation across all the TCGA/TARGET samples (r = 0.59). This evidence concerns the gene FOXP3 and gastric cancer.